Works matching IS 02698811 AND DT 2025 AND VI 39 AND IP 1

Results: 9

Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression.
Published in:
Journal of Psychopharmacology, 2025, v. 39, n. 1, p. 76, doi. 10.1177/02698811241276505
By:
- Gomes, Sarah Pereira;
- Lima, Sofia Rodrigues;
- Souza, Fabio Gomes de Matos;
- Bisol, Luísa Weber
Publication type:
Article
Is there a risk of addiction to ketamine during the treatment of depression? A systematic review of available literature.
Published in:
Journal of Psychopharmacology, 2025, v. 39, n. 1, p. 49, doi. 10.1177/02698811241303597
By:
- Ingrosso, Gianmarco;
- Cleare, Anthony J;
- Juruena, Mario F
Publication type:
Article
Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study.
Published in:
Journal of Psychopharmacology, 2025, v. 39, n. 1, p. 23, doi. 10.1177/02698811241301215
By:
- Beaglehole, Ben;
- Glue, Paul;
- Neehoff, Shona;
- Shadli, Shabah;
- McNaughton, Neil;
- Kimber, Bridget;
- Muirhead, Chrissie;
- Bie, Aroha de;
- Day-Brown, Rachel;
- Hughes-Medlicott, Natalie J
Publication type:
Article
Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm.
Published in:
Journal of Psychopharmacology, 2025, v. 39, n. 1, p. 29, doi. 10.1177/02698811241286726
By:
- MacConnel, Henry A;
- Earleywine, Mitch;
- Radowitz, Steven
Publication type:
Article
Ketamine for refractory depression: Save the best for last?
Published in:
Journal of Psychopharmacology, 2025, v. 39, n. 1, p. 5, doi. 10.1177/02698811241282646
By:
- Nigam, Kabir;
- King IV, Franklin;
- Espi Forcen, Fernando
Publication type:
Article
Ketamine: Therapeutic potential versus recreational misuse.
Published in:
Journal of Psychopharmacology, 2025, v. 39, n. 1, p. 3, doi. 10.1177/02698811241308935
By:
- Juruena, Mario F;
- Young, Allan H
Publication type:
Article
Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment.
Published in:
Journal of Psychopharmacology, 2025, v. 39, n. 1, p. 8, doi. 10.1177/02698811241273850
By:
- Barrios, Karen P;
- Connolly, Dean J;
- Ferris, Jason A;
- Maier, Larissa J;
- Barratt, Monica J;
- Winstock, Adam R;
- Puljević, Cheneal;
- Gilchrist, Gail
Publication type:
Article
Combining bioinformatics, network pharmacology and artificial intelligence to predict the target genes of S-ketamine for treating major depressive disorder.
Published in:
Journal of Psychopharmacology, 2025, v. 39, n. 1, p. 66, doi. 10.1177/02698811241268884
By:
- Xianjin, Zhou;
- Fuyi, Shen;
- Ti, Yang;
- Shan, Li;
- Kang, Zhao;
- Ying, Wang;
- Shengqiong, Deng
Publication type:
Article
Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment.
Published in:
Journal of Psychopharmacology, 2025, v. 39, n. 1, p. 38, doi. 10.1177/02698811241267837
By:
- Gutiérrez-Rojas, Luis;
- Vendrell-Serres, Julia;
- Ramos-Quiroga, J. Antoni;
- Etxeandia-Pradera, Jon Iñaki;
- Aguilar, Eduardo;
- De Santiago-Díaz, Ana Isabel;
- Hernández-Huerta, Daniel;
- Tordera, Vicente;
- Vázquez-Ventoso, Carlos;
- Bolívar, Moisés;
- Abril, Asunción;
- Catalán-Barragán, Rubén;
- García-Jiménez, Jesús
Publication type:
Article